Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients
出版年份 2021 全文链接
标题
Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-06-14
DOI
10.3389/fimmu.2021.684014
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- What we know about covid-19 reinfection so far
- (2021) Chris Stokel-Walker BMJ-British Medical Journal
- Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
- (2021) Yunjiao Zhou et al. Cell Reports
- C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2–infected primary human airway epithelia
- (2021) Wilfried Posch et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
- (2020) Jin-jin Zhang et al. ALLERGY
- A novel coronavirus outbreak of global health concern
- (2020) Chen Wang et al. LANCET
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
- (2020) Juanjuan Zhao et al. CLINICAL INFECTIOUS DISEASES
- Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020
- (2020) Kenji Mizumoto et al. Eurosurveillance
- Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
- (2020) Ling Ni et al. IMMUNITY
- Immunology of COVID-19: current state of the science
- (2020) Nicolas Vabret et al. IMMUNITY
- Risk-adapted Treatment Strategy For COVID-19 Patients
- (2020) Changcheng Zheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia
- (2020) Fan Wang et al. JOURNAL OF INFECTIOUS DISEASES
- Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
- (2020) Qingqing Lin et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Human neutralizing antibodies elicited by SARS-CoV-2 infection
- (2020) Bin Ju et al. NATURE
- Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
- (2020) Mingfeng Liao et al. NATURE MEDICINE
- Coronavirus disease 2019 (COVID-19): a clinical update
- (2020) Min Zhou et al. Frontiers of Medicine
- Tackling COVID‐19 infection through complement‐targeted immunotherapy
- (2020) Sonata Jodele et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Natural History and Transmission Potential of Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection
- (2020) Nguyen Van Vinh Chau et al. CLINICAL INFECTIOUS DISEASES
- Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta‐analysis
- (2020) Jingjing He et al. JOURNAL OF MEDICAL VIROLOGY
- Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis
- (2020) Julien Carvelli et al. NATURE
- SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- (2020) Nina Le Bert et al. NATURE
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- The implications of silent transmission for the control of COVID-19 outbreaks
- (2020) Seyed M. Moghadas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea
- (2020) Seungjae Lee et al. JAMA Internal Medicine
- Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome
- (2020) Daniela Weiskopf et al. Science Immunology
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- Genomic evidence for reinfection with SARS-CoV-2: a case study
- (2020) Richard L Tillett et al. LANCET INFECTIOUS DISEASES
- Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
- (2020) Yanchun Peng et al. NATURE IMMUNOLOGY
- Complement activation and endothelial perturbation parallel COVID-19 severity and activity
- (2020) Massimo Cugno et al. JOURNAL OF AUTOIMMUNITY
- Complement activation by IgG containing immune complexes regulates the interaction of C1q with its ligands
- (2019) C. Garren Hester et al. MOLECULAR IMMUNOLOGY
- The CD8 T Cell Response to Respiratory Virus Infections
- (2018) Megan E. Schmidt et al. Frontiers in Immunology
- Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
- (2018) Lisa E. Gralinski et al. mBio
- Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
- (2016) Oi-Wing Ng et al. VACCINE
- Fc receptors in antibody-dependent enhancement of viral infections
- (2015) Adam Taylor et al. IMMUNOLOGICAL REVIEWS
- Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis
- (2014) Hongmei Gu et al. FASEB JOURNAL
- Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes
- (2012) Wilfried Posch et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Complement and viral pathogenesis
- (2011) Kristina A. Stoermer et al. VIROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started